Published in PLoS One on October 09, 2015
Leveraging big data to transform target selection and drug discovery. Clin Pharmacol Ther (2016) 0.84
Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures. PLoS One (2016) 0.76
Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases. Gastroenterology (2016) 0.76
KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies. Oncotarget (2016) 0.75
Aurora-B kinase pathway controls the lateral to end-on conversion of kinetochore-microtubule attachments in human cells. Nat Commun (2017) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Community structure in social and biological networks. Proc Natl Acad Sci U S A (2002) 29.77
The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science (2006) 25.99
International network of cancer genome projects. Nature (2010) 20.35
NCBI GEO: mining millions of expression profiles--database and tools. Nucleic Acids Res (2005) 17.61
Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature (2012) 15.91
The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell (2003) 8.34
ArrayExpress update--an archive of microarray and high-throughput sequencing-based functional genomics experiments. Nucleic Acids Res (2010) 7.67
Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov (2004) 7.57
Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med (2011) 5.30
The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer (2007) 4.40
Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci U S A (2010) 4.35
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res (2012) 4.34
Depletion of centromeric MCAK leads to chromosome congression and segregation defects due to improper kinetochore attachments. Mol Biol Cell (2003) 3.30
Kinase-independent function of cyclin E. Mol Cell (2007) 3.03
Mitosis: a matter of getting rid of the right protein at the right time. Trends Cell Biol (2005) 2.74
Human disease-drug network based on genomic expression profiles. PLoS One (2009) 2.62
A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov (2013) 2.46
SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol (2005) 2.24
Identification of a small molecule inhibitor of Sir2p. Proc Natl Acad Sci U S A (2001) 2.23
mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab (2011) 2.11
Microtubules are acetylated in domains that turn over slowly. J Cell Sci (1989) 1.86
Drug-induced regulation of target expression. PLoS Comput Biol (2010) 1.65
Transcriptional data: a new gateway to drug repositioning? Drug Discov Today (2012) 1.40
Androgen receptor on the move: boarding the microtubule expressway to the nucleus. Cancer Res (2012) 1.35
The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation. Genes Dev (2013) 1.29
sscMap: an extensible Java application for connecting small-molecule drugs using gene-expression signatures. BMC Bioinformatics (2009) 1.20
Lateral to end-on conversion of chromosome-microtubule attachment requires kinesins CENP-E and MCAK. Curr Biol (2013) 1.10
The emergence of genome-based drug repositioning. Sci Transl Med (2011) 1.07
Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer. PLoS Comput Biol (2012) 1.06
Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors. Arthritis Rheum (2011) 0.99
Direct interaction between BKCa potassium channel and microtubule-associated protein 1A. FEBS Lett (2004) 0.97
Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinoma. PLoS One (2011) 0.92
Automated tracking of mitotic spindle pole positions shows that LGN is required for spindle rotation but not orientation maintenance. Cell Cycle (2013) 0.90
Identification of small molecules enhancing autophagic function from drug network analysis. Autophagy (2010) 0.88
Furry promotes acetylation of microtubules in the mitotic spindle by inhibition of SIRT2 tubulin deacetylase. J Cell Sci (2013) 0.88
Fluoxetine administration modulates the cytoskeletal microtubular system in the rat hippocampus. Synapse (2009) 0.83
Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies. Neoplasia (2012) 0.82
Changes in dendritic structure and function following hippocampal lesions: correlations with developmental events? Prog Neurobiol (1998) 0.81
MT7, a novel compound from a combinatorial library, arrests mitosis via inhibiting the polymerization of microtubules. Invest New Drugs (2009) 0.81
An antagonist of ATP-regulated potassium channels, the guanidine derivative U-37883A, stimulates the synthesis of phosphatidylserine in rat liver endoplasmic reticulum membranes. FEBS Lett (1997) 0.78
Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance. BMC Cancer (2013) 0.77
Bioavailability of glipizide and its effect on blood glucose and insulin levels in patients with non-insulin-dependent diabetes. Diabetes Care (1984) 0.77